|Articles|March 24, 2016
SCRS Welcomes Nimblify to Partner Program
Nimblify, Inc., developer of a patient-centric payment system and a benchmarking tool for sites, among other technologies, will participate as a Global Impact Partner.
Advertisement
The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to the interests of clinical research sites, announced a two-year relationship with Nimblify, Inc., developer of a patient-centric payment system and a benchmarking tool for sites, among other technologies. Nimblify will participate as a Global Impact Partner (GIP) and align with 33 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5